Recombinant Rat Taste receptor type 2 member 13 (Tas2r13) is a protein produced through recombinant DNA technology, specifically designed for research purposes. This receptor is part of the bitter taste receptor family, which plays a crucial role in detecting bitter compounds in food and beverages. Tas2r13 is expressed in the rat genome and is used in scientific studies to understand bitter taste perception and its implications in various physiological processes.
The recombinant rat Tas2r13 is typically produced using an in vitro E. coli expression system. This method involves inserting the gene encoding Tas2r13 into E. coli bacteria, which then express the protein. The recombinant protein is purified and made available for research applications, such as studying bitter taste mechanisms and potential interactions with various compounds.
| Product Details | Description |
|---|---|
| Code | CSB-CF862400RA |
| Source | In vitro E. coli expression system |
| KEGG | rno:78983 |
| STRING | 10116.ENSRNOP00000007521 |
| UniGene | Rn.48786 |
Research on Tas2r13 and other bitter taste receptors has shown that genetic variations can influence alcohol consumption and bitter taste perception. For instance, studies on human TAS2R13 have found associations between genetic variations and alcohol intake patterns . While specific studies on recombinant rat Tas2r13 might be limited, its use in research can help elucidate the mechanisms of bitter taste perception and its role in dietary preferences and health outcomes.
Docking analysis of phenolic compounds with TAS2R receptors, including TAS2R13, has revealed diverse inhibition mechanisms. These compounds interact with the receptor using hydrophobic pockets, similar to those used by denatonium, a known bitter compound . Understanding these interactions can provide insights into how different substances affect bitter taste perception.
Recombinant Rat Taste receptor type 2 member 13 (Tas2r13) is a receptor potentially involved in bitterness perception and is gustducin-linked. It may contribute to sensing the gastrointestinal tract's chemical composition. Receptor activation may stimulate alpha-gustducin, mediate PLC-beta-2 activation, and subsequently gate TRPM5.
Tas2r13 is expressed in the posterior papillae of the tongue, similar to the expression pattern observed for other Tas2r family members in mice. Based on studies of mouse taste receptors, we can infer that rat Tas2r13 is likely expressed in a subset of taste receptor cells in the vallate papillae . The expression level may vary compared to other Tas2r genes, as observed in mice where some receptors show high abundance (reaching ~20% of α-gustducin mRNA levels) while others show much lower expression .
To determine the precise expression pattern, researchers should employ:
Quantitative RT-PCR to measure relative expression levels
In situ hybridization to visualize cellular localization
Single-cell RNA sequencing to identify co-expression patterns with other taste-related genes
Based on studies of related bitter taste receptors, Tas2r13 likely has expression beyond gustatory tissues. Mouse studies have demonstrated that bitter taste receptor clusters are expressed in various organs including the heart, vascular smooth cells, and adipose tissue . For rat Tas2r13, researchers should investigate expression in:
Cardiovascular tissues (heart, vascular smooth muscle cells)
Gastrointestinal tract (particularly intestinal epithelium)
Respiratory system
Testis
Methodologically, a BAC-based transgenic approach using the Tas2r13 promoter driving a reporter gene (such as CreERT2 or EGFP) would enable comprehensive tissue mapping . Alternatively, tissue-specific RT-PCR with primers designed for rat Tas2r13 can provide initial expression data.
To validate functionality of recombinant Rat Tas2r13:
Heterologous expression system: Express the receptor in HEK293T cells with either Gα15 or Gα16gust44, with the latter providing higher sensitivity for detecting receptor activation .
Calcium imaging assay: Use calcium-sensitive dyes to monitor intracellular calcium release upon receptor activation.
Compound screening: Test against a library of bitter compounds to determine the activation profile.
Control experiments: Include known bitter taste receptor agonists and antagonists as positive and negative controls.
Dose-response analysis: Determine EC50 values for identified agonists.
Note that sensitivity may vary depending on the G-protein coupled to the receptor, as demonstrated for mouse Tas2r105 where responses were stronger with Gα16gust44 compared to Gα15 .
Genetic variations in taste receptors can significantly impact receptor function and ligand specificity. For human TAS2R13, variations are associated with differences in alcohol consumption, suggesting functional consequences of these polymorphisms .
Methodological approach:
Sequence multiple rat strains to identify naturally occurring variations in Tas2r13.
Site-directed mutagenesis to introduce specific amino acid changes in the recombinant receptor.
Functional comparison using calcium imaging assays to determine how variants affect:
Agonist binding affinity
Signal transduction efficiency
Receptor desensitization
Homology modeling based on known GPCR structures to predict how amino acid substitutions affect the binding pocket.
In vivo behavioral testing with rats carrying different Tas2r13 variants to determine phenotypic consequences.
Key positions to investigate would include those in the N-terminal domain and transmembrane regions, as these areas are critical for ligand recognition in taste receptors .
The expression of functional G protein-coupled receptors (GPCRs) like Tas2r13 presents significant challenges. Based on studies with related receptors, we recommend:
| Expression System | Advantages | Disadvantages | Optimization Strategies |
|---|---|---|---|
| HEK293T cells | Well-established for taste receptors, endogenous G-proteins | May lack specific cofactors | Co-expression with Gα16gust44 to enhance signaling |
| Sf9 insect cells | High expression levels, proper folding | More complex culture conditions | Use of baculovirus expression vector |
| Yeast systems | Cost-effective, scalable | May have different post-translational modifications | Codon optimization for yeast expression |
| Cell-free systems | Rapid production, membrane protein-friendly | Lower yields | Addition of lipid nanodiscs |
For functional studies, HEK293T cells co-expressing Gα16gust44 are recommended as they provide higher sensitivity than systems using Gα15 . For structural studies requiring larger protein quantities, insect cell systems may be preferable.
Taste receptors show species-specific differences in ligand recognition despite sequence homology. To characterize Rat Tas2r13 specificity compared to orthologs:
Comparative functional assays:
Express rat, mouse, and human orthologs in the same cell system
Test against an identical panel of bitter compounds
Use the same signal detection method (calcium imaging)
Chimeric receptor approach:
Generate chimeric receptors with domains from different species
Identify regions responsible for species-specific responses
Data analysis:
Compare EC50 values for shared ligands
Identify compounds that activate only species-specific orthologs
Calculate selectivity indices
Mouse studies show that bitter taste receptors vary widely in their tuning breadth, from very selective to broadly tuned receptors recognizing many compounds . Determining where Rat Tas2r13 falls on this spectrum is essential for understanding its physiological role.
Bitter taste receptors in non-gustatory tissues may utilize different signaling pathways than in taste cells. To investigate Rat Tas2r13 signaling:
Pathway analysis:
Examine coupling to different G-proteins (Gαgustducin, Gαi, Gαq/11)
Measure second messengers (calcium, cAMP, IP3)
Use specific pathway inhibitors to determine signaling dependencies
Tissue-specific differences:
Compare signaling in primary cells from different tissues expressing Tas2r13
Analyze co-expression with potential signaling partners
Physiological outcomes:
In vascular tissue: measure contractility
In immune cells: assess cytokine production
In gut cells: monitor hormone release
Bitter taste receptors in non-gustatory tissues may have evolved different sensitivities and coupling mechanisms to serve tissue-specific functions . Understanding these differences is crucial for interpreting physiological roles of Tas2r13 outside the oral cavity.
Tas2r bitter receptors are expressed along the gastrointestinal tract, suggesting roles beyond taste perception. For Rat Tas2r13 intestinal expression studies:
Tissue sampling strategy:
Collect samples from multiple regions (duodenum, jejunum, ileum, colon)
Separate epithelial cells from underlying tissues
Consider crypt-villus axis for regional differences
Detection methods:
RT-qPCR with region-specific primers
RNAscope in situ hybridization for cellular resolution
Cell type-specific markers to identify expressing cell populations
Functional validation:
Organoid cultures from intestinal epithelium
Calcium imaging with bitter compounds
Measurements of physiological responses (mucus secretion, hormone release)
Studies in mice revealed that some Tas2r genes (like Tas2r131) are expressed in specific intestinal cell types such as goblet cells . Determining if Rat Tas2r13 shows similar patterns will provide insights into its functional role in intestinal chemosensation.
Antibody validation is critical for reliable detection of Tas2r13. A comprehensive validation protocol should include:
Positive controls:
Negative controls:
Tissues from Tas2r13 knockout rats (if available)
Pre-adsorption of antibody with immunizing peptide
Secondary antibody only controls
Specificity tests:
Western blot showing band at predicted molecular weight
Immunoprecipitation followed by mass spectrometry
Cross-reactivity testing with closely related Tas2r family members
Method-specific validations:
For IHC/ICC: Compare multiple fixation protocols
For flow cytometry: Compare with mRNA expression
For ELISA: Establish standard curves with recombinant protein
Given the high sequence similarity among Tas2r family members, special attention must be paid to antibody specificity to avoid cross-reactivity with other bitter taste receptors.
Researchers often encounter contradictions between heterologous expression studies and in vivo observations. When analyzing such discrepancies:
Consider system differences:
Expression levels in heterologous systems typically exceed physiological levels
Absence of native regulatory proteins in cell lines
G-protein coupling differences (e.g., Gα16gust44 vs. native G-proteins)
Reconciliation approaches:
Data integration framework:
Establish physiologically relevant concentration ranges
Consider receptor sensitivity in different contexts
Account for potential receptor heteromerization
Studies with mouse Tas2r105 demonstrated that the choice of G-protein (Gα15 vs. Gα16gust44) significantly affected the detection of low-efficacy agonists, explaining apparent contradictions in previous reports . Similar considerations may apply to Rat Tas2r13 studies.
When analyzing large-scale screening data for Rat Tas2r13:
Data normalization:
Normalize to positive control responses (e.g., ATP in calcium imaging)
Consider Z-score normalization for plate-to-plate comparisons
Account for baseline drift during long experiments
Statistical methods:
Use non-parametric tests if normality cannot be assumed
Apply false discovery rate corrections for multiple comparisons
Implement concentration-response modeling (Hill equation fitting)
Classification criteria:
Establish clear thresholds for agonist classification
Consider both efficacy (maximum response) and potency (EC50)
Validate hits with repeated independent experiments
Advanced analysis:
Structure-activity relationship analysis for related compounds
Principal component analysis to identify chemical features determining activity
Hierarchical clustering to group compounds by response patterns
Mouse Tas2r studies categorized receptors from specialists (responding to few compounds) to generalists (responding to >30% of compounds tested) . Similar categorization could be applied to Rat Tas2r13 following comprehensive ligand screening.
Researchers frequently encounter challenges when expressing functional taste receptors. For Rat Tas2r13:
Poor surface expression:
Problem: Receptor retained in endoplasmic reticulum
Solution: Add N-terminal tags known to enhance surface expression
Validation: Confirm membrane localization with surface biotinylation
Weak functional responses:
Non-specific responses:
Problem: Compounds activate cells independent of receptor
Solution: Include mock-transfected controls for all test compounds
Validation: Confirm response inhibition with receptor antagonists
Inconsistent results:
Problem: Variation between experiments
Solution: Standardize cell passage number, expression time, and assay conditions
Validation: Include internal standards in each experiment
Species mismatch issues:
Problem: Using signaling components from different species
Solution: Use species-matched G-proteins and signal transduction elements
Validation: Compare with native tissue responses when possible
Taste receptor desensitization can complicate experimental interpretation. Strategies to address this include:
Pulse stimulation protocols:
Brief agonist applications with washout periods
Monitor recovery time course after stimulation
Use automated perfusion systems for precise timing
Phosphorylation analysis:
Monitor receptor phosphorylation status after stimulation
Identify kinases involved in desensitization
Create phosphorylation-resistant mutants for mechanism studies
Internalization monitoring:
Quantify surface expression before and after stimulation
Track receptor trafficking using fluorescently tagged receptors
Measure recycling rates following internalization
Adaptation mechanisms:
Investigate downstream signaling component regulation
Study transcriptional feedback on receptor expression
Examine cross-desensitization with other taste receptors
Understanding desensitization mechanisms is particularly important when studying physiological roles of Tas2r13 in contexts involving prolonged or repeated exposure to bitter compounds.
As research on bitter taste receptors expands beyond taste perception, several innovative approaches are emerging:
Organoid systems:
3D cultures of taste papillae or intestinal epithelium
Maintenance of cellular diversity and organization
Allows for long-term functional studies
CRISPR-based approaches:
Generation of reporter knock-in rat lines
Tissue-specific conditional knockouts
Single nucleotide editing to study variant effects
Intravital imaging:
Real-time monitoring of receptor activation in live animals
Genetically encoded calcium or cAMP sensors
Correlation with physiological responses
Multi-omics integration:
Combining transcriptomics, proteomics, and metabolomics
Systems biology approaches to understand receptor networks
Pathway analysis in different tissues expressing Tas2r13
Single-cell approaches:
scRNA-seq to identify cell populations expressing Tas2r13
Spatial transcriptomics to map expression in tissue context
Cell-specific functional characterization
These emerging methods will help resolve outstanding questions about the physiological roles of Rat Tas2r13 in both gustatory and extra-gustatory tissues .
Comparative studies of Tas2r13 across species can provide insights into evolutionary adaptation:
Phylogenetic analysis:
Compare sequences of Tas2r13 orthologs across mammalian species
Identify regions under positive or purifying selection
Correlate with dietary specialization and ecological niches
Functional divergence:
Compare ligand specificity between species
Identify species-specific agonists and antagonists
Determine if extra-oral functions are conserved across species
Receptor-ligand co-evolution:
Study how dietary bitter compounds shaped receptor evolution
Examine correlation between food preferences and receptor variants
Investigate potential pathogen-driven selection pressures
Genomic context analysis:
Compare gene clustering and regulatory elements across species
Examine duplication and pseudogenization patterns
Study epigenetic regulation in different tissues